Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The study was conducted according to an appropriate OECD test guideline, with acceptable restrictions. The restrictions were that there was no information on cytotoxicity, and only .

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Version / remarks:
1983
Deviations:
yes
Remarks:
no information on cytotoxicity
GLP compliance:
yes
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Reference substance name:
Triethoxyisobutylsilane
EC Number:
402-810-3
EC Name:
Triethoxyisobutylsilane
IUPAC Name:
Triethoxyisobutylsilane
Constituent 2
Reference substance name:
017980-47-1
Cas Number:
017980-47-1
IUPAC Name:
017980-47-1

Method

Species / strain
Species / strain / cell type:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with and without
Metabolic activation system:
Aroclor induced rat liver S9
Test concentrations with justification for top dose:
25-150 µg/ml
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: ethanol;
- Justification for choice of solvent/vehicle: none given in report
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
ethylmethanesulphonate
Remarks:
without activation

Migrated to IUCLID6: 500 µg/ml
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
cyclophosphamide
Remarks:
with activation

Migrated to IUCLID6: 5 µg/ml
Details on test system and experimental conditions:
ACTIVATION Aroclor induced rat liver S9 containing NADP as cofactor, final concentration ca 1.5% S9-mix/culture

METHOD OF APPLICATION: in medium


DURATION

- Exposure duration: 3 or 21 hours

- Expression time (cells in growth medium): 15 hours after exposure (3 h treatment)

- Fixation time (start of exposure up to fixation or harvest of cells):21 hours


SPINDLE INHIBITOR (cytogenetic assays): 0.25 ml colcemid solution (10 µg/ml) added 2.5 h before end of incubation time

STAIN (for cytogenetic assays): Giesma


NUMBER OF REPLICATIONS: duplicate cultures


NUMBER OF CELLS EVALUATED: 5000 cells/culture (mitotic index); 100/culture (chromosome analysis)


DETERMINATION OF CYTOTOXICITY

- Method: mitotic index


OTHER EXAMINATIONS:

- Determination of polyploidy: yes

- Determination of endoreplication: yes

Evaluation criteria:
Substance considered positive when parallel cultures at one dose level repeatedly produce aberrations in more than 10% analyzed cells (gaps excluded). Dose dependency may provide further evidence for clastogenicity.
Statistics:
Only done if there was a significant increase in the number of aberrations

Results and discussion

Test results
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 200 µg/ml in preliminary test
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Table 1 Results of preliminary cytotoxicity assay

Concentration µg/ml

Mitotic Index

Solvent control

+MA

-MA

Positive control

115.8

151.6

50.0

88.6

116.4

100.0

109.2

128.8

200.0

48.6

91.2

400.0

0

0

600.0

0

0

800.0

0

0

1000.0

0

0

1250.0

0

0

2500.0

0

0

1500.0

0

0

Table 2 Results of chromosomal aberration test with cultured mammalian cells (V79)

Treatment group µg/ml Activation Exposure time hrs % Cells with aberrations + gaps % Cells with aberrations - gaps
Solvent control  - 21 4.0 0.5
Positive control  - 21 28.0 14.5
25  - 21 8.5 1.0
50  - 21 6.0 2.0
100  - 21 5.0 0.0
150  - 21 8.5 1.5
Solvent control  + 3 12.5 3.0
25  + 3 8.5 0.5
50  + 3 10.5 2.0
100  + 3 10.0 2.0
150  + 3 8.0 2.0
Solvent control  + 3 14.5 2.5
25  + 3 11.0 3.5
50  + 3 1.5 0.5
100  + 3 9.5 3.5
150  + 3 9.5 3.0
Solvent control  + 3 11.5 2.5
Positive control  + 3 32.5 16.5
25  + 3 12.5 3.5
50  + 3 7.5 2.5
100  + 3 10.0 3.0
150  + 3 8.5 1.5

The incorporation of an additional experiment using recovery times longer than 1.5 cell cycles (maybe 40-48 hours) would have been a beneficial add-on to this study since some chemicals have the ability to cause mitotic arrest, which may lead to a genotoxic result.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative with and without metabolic activation

Triethoxyisobutylsilane has been tested in a valid study according to OECD 473 and under GLP, up to concentrations that could be expected to be cytotoxic.. No increase in the number of cells with aberrations was observed either with or without activation. Solvent and positive controls gave expected results. It is concluded that the test substance is negative for the induction of chromosome aberrations under the conditions of this study.